| |
| |
|
| Insider
Information: |
Robinson James George |
| Relationship: |
Director, 10% Owner |
| City: |
Baltimore |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
4,782,065 |
|
|
Indirect Shares
|
99,100 |
|
|
| Direct
Value |
$1,243,337 |
|
|
|
Indirect Value
|
$25,766 |
|
|
| Total
Shares |
4,881,165 |
|
|
| Total
Value |
$1,269,103 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-2.0
|
0.0
|
| Percentage
Gain/Loss : |
 -28.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Nymox Pharmaceutical Corporation |
NYMX |
Director, 10% Owner |
2023-04-27 |
4,782,065 |
2017-08-03 |
99,100 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NYMX |
Nymox Pharmaceutical Corp... |
Director |
– • • |
2023-04-27 |
4/A |
B |
$0.47 |
$18,800 |
D/D |
40,000 |
4,782,065 |
3.92 |
- |
|
| NYMX |
Nymox Pharmaceutical Corp... |
Director |
– • • |
2023-04-25 |
4/A |
B |
$0.45 |
$18,000 |
D/D |
40,000 |
4,742,065 |
3.92 |
- |
|
| NYMX |
Nymox Pharmaceutical Corp... |
Director |
– • – |
2021-04-22 |
4 |
B |
$2.05 |
$56,215 |
D/D |
27,000 |
3,550,550 |
2.39 |
% |
|
| NYMX |
Nymox Pharmaceutical Corp... |
Director |
– • – |
2021-04-21 |
4 |
B |
$2.08 |
$27,058 |
D/D |
13,000 |
3,523,550 |
2.39 |
% |
|
| NYMX |
Nymox Pharmaceutical Corp... |
Director |
– • – |
2019-07-10 |
4 |
B |
$1.72 |
$12,104 |
D/D |
7,000 |
3,510,550 |
2.39 |
- |
|
| NYMX |
Nymox Pharmaceutical Corp... |
Director |
– • – |
2019-07-09 |
4 |
B |
$1.63 |
$11,400 |
D/D |
7,000 |
3,503,550 |
2.39 |
- |
|
| NYMX |
Nymox Pharmaceutical Corp... |
Director |
– • – |
2019-07-05 |
4 |
B |
$1.45 |
$13,049 |
D/D |
9,000 |
3,496,550 |
2.39 |
- |
|
| NYMX |
Nymox Pharmaceutical Corp... |
Director |
– • – |
2019-07-03 |
4 |
B |
$1.54 |
$12,354 |
D/D |
8,000 |
3,487,550 |
2.39 |
- |
|
| NYMX |
Nymox Pharmaceutical Corp... |
Director |
– • – |
2019-07-01 |
4 |
B |
$1.36 |
$12,305 |
D/D |
9,000 |
3,479,550 |
2.39 |
- |
|
| NYMX |
Nymox Pharmaceutical Corp... |
Director |
– • – |
2019-06-29 |
4 |
B |
$1.48 |
$149,931 |
D/D |
8,890 |
3,470,550 |
2.39 |
- |
|
| NYMX |
Nymox Pharmaceutical Corp... |
Director |
– • – |
2019-06-28 |
4 |
B |
$1.48 |
$1,637 |
D/D |
1,110 |
3,461,660 |
2.31 |
- |
|
| NYMX |
Nymox Pharmaceutical Corp... |
Director |
– • – |
2019-06-27 |
4 |
B |
$1.54 |
$14,023 |
D/D |
9,000 |
3,460,550 |
2.39 |
- |
|
| NYMX |
Nymox Pharmaceutical Corp... |
Director |
– • – |
2019-06-26 |
4 |
B |
$1.71 |
$13,680 |
D/D |
8,000 |
3,451,550 |
2.39 |
- |
|
| NYMX |
Nymox Pharmaceutical Corp... |
Director |
– • – |
2019-06-25 |
4 |
B |
$1.73 |
$15,533 |
D/D |
9,000 |
3,443,550 |
2.39 |
- |
|
| NYMX |
Nymox Pharmaceutical Corp... |
Director |
– • – |
2019-06-20 |
4 |
B |
$1.77 |
$15,918 |
D/D |
9,000 |
3,434,550 |
2.39 |
- |
|
| NYMX |
Nymox Pharmaceutical Corp... |
Director |
– • – |
2019-06-19 |
4 |
B |
$1.69 |
$13,529 |
D/D |
8,000 |
3,425,550 |
2.39 |
- |
|
| NYMX |
Nymox Pharmaceutical Corp... |
Director |
– • – |
2019-06-18 |
4 |
B |
$1.65 |
$15,046 |
D/D |
9,000 |
3,417,550 |
2.39 |
- |
|
| NYMX |
Nymox Pharmaceutical Corp... |
Director |
– • – |
2019-06-13 |
4 |
B |
$1.42 |
$11,344 |
D/D |
8,000 |
3,408,550 |
2.39 |
- |
|
| NYMX |
Nymox Pharmaceutical Corp... |
Director |
– • – |
2019-06-11 |
4 |
B |
$1.42 |
$13,149 |
D/D |
9,000 |
3,400,550 |
2.39 |
- |
|
| NYMX |
Nymox Pharmaceutical Corp... |
Director |
– • – |
2019-06-10 |
4 |
B |
$1.54 |
$12,288 |
D/D |
8,000 |
3,391,550 |
2.39 |
- |
|
| NYMX |
Nymox Pharmaceutical Corp... |
Director |
– • – |
2019-06-06 |
4 |
B |
$1.52 |
$15,648 |
D/D |
10,000 |
3,383,550 |
2.39 |
- |
|
| NYMX |
Nymox Pharmaceutical Corp... |
Director |
– • – |
2019-06-05 |
4 |
B |
$1.53 |
$17,093 |
D/D |
11,000 |
3,373,550 |
2.39 |
- |
|
| NYMX |
Nymox Pharmaceutical Corp... |
Director |
– • – |
2019-06-03 |
4 |
B |
$1.62 |
$14,598 |
D/D |
9,000 |
3,362,550 |
2.39 |
- |
|
| NYMX |
Nymox Pharmaceutical Corp... |
Director |
– • – |
2019-05-31 |
4 |
B |
$1.58 |
$15,925 |
D/D |
10,000 |
3,353,550 |
2.39 |
- |
|
| NYMX |
Nymox Pharmaceutical Corp... |
Director |
– • – |
2019-05-30 |
4 |
B |
$1.76 |
$14,967 |
D/D |
8,500 |
3,343,550 |
2.39 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
